The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures
Open accessAbstract
Purpose: A relationship between mean heart dose (MHD) and acute coronary event (ACE) rate was reported in a study of patients with breast cancer (BC). The main objective of our cohort study was to validate this relationship and investigate if other dose-distribution parameters are better predictors for ACEs than MHD. Patients and Methods: The cohort consisted of 910 consecutive female patients with BC treated with radiotherapy (RT) after breast-conserving surgery. The primary end point was cumulative incidence of ACEs within 9 years of follow-up. Both MHD and various dose-distribution parameters of the cardiac substructures were collected from three-dimensional computed tomography planning data. Results: The median MHD was 2.37 Gy (range, 0.51 to 15.25 Gy). The median follow-up time was 7.6 years (range, 0.1 to 10.1 years), during which 30 patients experienced an ACE. The cumulative incidence of ACE increased by 16.5% per Gy (95% CI, 0.6 to 35.0; P = .042). Analysis showed that the volume of the left ventricle receiving 5 Gy (LV-V5) was the most important prognostic dose-volume parameter. The most optimal multivariable normal tissue complication probability model for ACEs consisted of LV-V5, age, and weighted ACE risk score per patient (c-statistic, 0.83; 95% CI, 0.75 to 0.91). Conclusion: A significant dose-effect relationship was found for ACEs within 9 years after RT. Using MHD, the relative increase per Gy was similar to that reported in the previous study. In addition, LV-V5 seemed to be a better predictor for ACEs than MHD. This study confirms the importance of reducing exposure of the heart to radiation to avoid excess risk of ACEs after radiotherapy for BC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154 · cited 1×
“Because the number of events was limited, we decided not to add more than these three factors to the model to prevent overfitting.(14,15) For internal validation and adjustment for possible internal optimism for both the c-statistics and some estimators, bootstrapping was performed by using 1,000 random subsets.”
MethodCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Radiation Dose–Volume Effects in the Lung
Marks, L. B., Bentzen, S. M., Deasy, J. O., Kong, F.-M. (., Bradley, J. D., Vogelius, I. S., El Naqa, I., Hubbs, J. L., Lebesque, J. V., Timmerman, R. D., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.091 · Cited by 1,103
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Concato, J., Peduzzi, P., Holford, T. R., & Feinstein, A. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00510-2 · Cited by 797
Feng, M., Moran, J. M., Koelling, T., Chughtai, A., Chan, J. L., Freedman, L., Hayman, J. A., Jagsi, R., Jolly, S., Larouere, J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.058 · Cited by 715
Langendijk, J. A., Lambin, P., De Ruysscher, D., Widder, J., Bos, M., & Verheij, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.007 · Cited by 549
Self-citationCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · European Urology · doi:10.1016/j.eururo.2014.11.025 · Cited by 439
Klein, S., van der Heide, U. A., Lips, I. M., van Vulpen, M., Staring, M., & Pluim, J. P. W. (2008) · Medical Physics · doi:10.1118/1.2842076 · Cited by 414
Harris, E. E. R., Correa, C., Hwang, W.-T., Liao, J., Litt, H. I., Ferrari, V. A., & Solin, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1037 · Cited by 393
Correa, C. R., Litt, H. I., Hwang, W.-T., Ferrari, V. A., Solin, L. J., & Harris, E. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6595 · Cited by 392
Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer
Nilsson, G., Holmberg, L., Garmo, H., Duvernoy, O., Sjögren, I., Lagerqvist, B., & Blomqvist, C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.5900 · Cited by 386
Taylor, C. W., Wang, Z., Macaulay, E., Jagsi, R., Duane, F., & Darby, S. C. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2292 · Cited by 332
Patt, D. A., & Giordano, S. H. (2007) · Breast Diseases: A Year Book Quarterly · doi:10.1016/s1043-321x(07)80352-3 · Cited by 305
Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., Tate, D. J., Horning, S. J., Hoppe, R. T., & Hancock, S. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0805 · Cited by 262
Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy: A Review
Plummer, C., Henderson, R. D., O'Sullivan, J. D., & Read, S. J. (2011) · Stroke · doi:10.1161/strokeaha.111.615203 · Cited by 257
Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study
Hooning, M. J., Aleman, B. M. P., van Rosmalen, A. J. M., Kuenen, M. A., Klijn, J. G. M., & van Leeuwen, F. E. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.022 · Cited by 207
Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
Ky, B., Vejpongsa, P., Yeh, E. T. H., Force, T., & Moslehi, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300218 · Cited by 170
Vallis, K. A., Pintilie, M., Chong, N., Holowaty, E. J., Douglas, P. S., Kirkbride, P., & Wielgosz, A. T. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1036 · Cited by 165
Radiation-induced heart disease in rats
Lauk, S., Kiszel, Z., Buschmann, J., & Trott, K.-R. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90314-1 · Cited by 146
Erven, K., Jurcut, R. O., Weltens, C. G., Giuşcă, S., Ector, J., Wildiers, H. P. M. W., den Bogaert, W. F. V., & Voigt, J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.004 · Cited by 130
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
Boekel, N. B., Schaapveld, M., Gietema, J. A., Russell, N. S., Poortmans, P. M., Theuws, J. C. M., Schinagl, D. A. X., Rietveld, D. H. F., Versteegh, M. I. M., Visser, O. J., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.040 · Cited by 128
Self-citationLorenzen, E. L., Taylor, C., Maraldo, M. V., Nielsen, M. H., Offersen, B. V., Andersen, M. R., ODwyer, D. B., Larsen, L., Duxbury, S., Jhitta, B., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.025 · Cited by 115
Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer
Boero, I. J., Paravati, A. J., Triplett, D. P., Hwang, L., Matsuno, R. K., Gillespie, E. F., Yashar, C. M., Moiseenko, V., Einck, J. P., Mell, L. K., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.018 · Cited by 114
Bradley, J. A., Dagan, R., Ho, M. W., Rutenberg, M. S., Morris, C. G., Li, Z., & Mendenhall, N. P. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.09.018 · Cited by 112
Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience
Miles, E. F., Larrier, N., Kelsey, C. R., Hubbs, J. L., Ma, J., Yoo, S., & Marks, L. B. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.011 · Cited by 105
Jacob, S., Pathak, A., Franck, D., Latorzeff, I., Jimenez, G., Fondard, O., Lapeyre, M., Colombier, D., Bruguière, É., Lairez, O., et al. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0627-5 · Cited by 94
Lin, A., Sharieff, W., Juhasz, J., Whelan, T. J., & Kim, D. (2016) · Breast Cancer · doi:10.1007/s12282-016-0676-5 · Cited by 46
Chen, A., Niermann, K. J., Deeley, M. A., & Dawant, B. M. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/1/93 · Cited by 42
Magné, N., Chargari, C., MacDermed, D. M., Conforti, R., Védrine, L., Spano, J., & Khayat, D. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.01.012 · Cited by 32
Cited by
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Banfill, K., Giuliani, M., Aznar, M., Franks, K., McWilliam, A., Schmitt, M., Sun, F., Vozenin, M. C., & Faivre Finn, C. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.002 · Cited by 272
Metadata
- Authors
- van den Bogaard, V. A. B., Ta, B. D. P., van der Schaaf, A., Bouma, A. B., Middag, A. M. H., Bantema-Joppe, E. J., van Dijk, L. V., van Dijk-Peters, F. B. J., Marteijn, L. A. W., de Bock, G. H., Burgerhof, J. G. M., Gietema, J. A., Langendijk, J. A., Maduro, J. H., & Crijns, A. P. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-04-10
- Volume
- 35
- Issue
- 11
- Pages
- 1171-1178
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2574924994
- Cited by
- 511
- References
- 35
- FWCI
- 35.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.